Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis

Assess the efficiency and cost-effectiveness of infliximab, cyclosporine and tacrolimus for the treatment of ulcerative colitis (UC). METHODS: A literature search identified studies that investigated infliximab, cyclosporine or tacrolimus compared with placebo in UC patients. Short-term, long-term r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xueqi, Li, Qiubo, Sun, Shijiang, Liang, Xi, Li, Huijing, Huang, Jing, Zhao, Tianhe, Hu, Jingnan, Liu, Jianxin, Hu, Zhenbiao, Duan, Yangyang, He, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794301/
https://www.ncbi.nlm.nih.gov/pubmed/36595876
http://dx.doi.org/10.1097/MD.0000000000031850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794301/
https://www.ncbi.nlm.nih.gov/pubmed/36595876
http://dx.doi.org/10.1097/MD.0000000000031850

Ejemplares similares